1. Home
  2. IMXI vs CERS Comparison

IMXI vs CERS Comparison

Compare IMXI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • CERS
  • Stock Information
  • Founded
  • IMXI 1994
  • CERS 1991
  • Country
  • IMXI United States
  • CERS United States
  • Employees
  • IMXI N/A
  • CERS N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • CERS EDP Services
  • Sector
  • IMXI Technology
  • CERS Technology
  • Exchange
  • IMXI Nasdaq
  • CERS Nasdaq
  • Market Cap
  • IMXI 278.2M
  • CERS 255.0M
  • IPO Year
  • IMXI N/A
  • CERS 1997
  • Fundamental
  • Price
  • IMXI $14.50
  • CERS $1.20
  • Analyst Decision
  • IMXI Buy
  • CERS Strong Buy
  • Analyst Count
  • IMXI 6
  • CERS 2
  • Target Price
  • IMXI $19.60
  • CERS $3.50
  • AVG Volume (30 Days)
  • IMXI 475.6K
  • CERS 1.1M
  • Earning Date
  • IMXI 11-07-2025
  • CERS 10-29-2025
  • Dividend Yield
  • IMXI N/A
  • CERS N/A
  • EPS Growth
  • IMXI N/A
  • CERS N/A
  • EPS
  • IMXI 1.65
  • CERS N/A
  • Revenue
  • IMXI $642,149,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • IMXI N/A
  • CERS $30.03
  • Revenue Next Year
  • IMXI $1.87
  • CERS $9.37
  • P/E Ratio
  • IMXI $8.81
  • CERS N/A
  • Revenue Growth
  • IMXI N/A
  • CERS 13.25
  • 52 Week Low
  • IMXI $8.58
  • CERS $1.12
  • 52 Week High
  • IMXI $22.37
  • CERS $2.24
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 70.52
  • CERS 41.61
  • Support Level
  • IMXI $14.45
  • CERS $1.17
  • Resistance Level
  • IMXI $14.57
  • CERS $1.35
  • Average True Range (ATR)
  • IMXI 0.13
  • CERS 0.07
  • MACD
  • IMXI -0.17
  • CERS -0.01
  • Stochastic Oscillator
  • IMXI 43.24
  • CERS 11.11

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: